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Transforming growth factor-beta (TGF-P) has a variety of roles including cell
growth inhibition, stimulation of proliferation, differentiation, apoptosis and extracellular
matrix (ECM) formation. TGF-P inhibits growth of the epithelial cells in the prostate
gland. The ability of TGF-(3 to inhibit cell growth enables it to act as a potent tumor
suppressor. Here, we show that TGF-P has different effects on proliferation in DU145
(TGF-P- responsive) and PC3M (TGF-p - resistant) prostate cancer cell lines. RT-PCR
analysis and Real-time PCR data have determined the varying levels of AP-1 family
members in both cell lines. In PC3M and DU145 cells, we have shown that TGF-p
exerts opposite effects on JunD, cFos and Fra2 expression, suggesting that AP-1 family
members may be involved in the differential effects of TGF-P in these cell lines. The
present observation confirms an intact inhibitory role of TGF-P on proliferation in
DU145 cells, and shows a non-inhibitory function in PC3M cell growth. In PC3M cells
TGF-p may exert effects leading to the metastatic nature of this cell line.
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Prostate Cancer is the second leading cause of cancer death among men in the
western world. The American Cancer Society estimates that 232,090 men will be
diagnosed with prostate cancer and an estimated 30,350 will die ofthe disease in 2005.
African-American men are especially at risk because they have the highest prostate
cancer incidence and mortality rates in the world. The incidence rate is approximately
65% higher and mortality rate double that of Caucasian males, who have the second
highest rate. During this year alone, 25,300 African-American men will be diagnosed
and 6,100 African-American men will die from prostate cancer. As a result of the
significant social and economic impact ofprostate cancer, it is imperative that we better
understand the mechanisms underlying the disease progression and develop specifically
targeted therapeutics.
Prostate cancer progression is mediated by androgens, mainly testosterone, and
growth factors, including epidermal growth factor (EGF), insulin-like growth factor
(IGF), and transforming growth factor-beta (TGF-P). These growth factors and
testosterone exert a synergistic effect on the growth, development, and function
ofthe prostate (24). The growth factor this research is focused on is TGF-(3, which is a
25 kilodalton dimeric polypeptide.
Transforming growth factor-beta (TGF-P 1, TGF-(32 and TGF-P3) is a family of
cytokines whose roles include a variety of cellular functions such as inhibition of
proliferation, stimulation of proliferation, differentiation, apoptosis, and extracellular
matrix formation (5). TGF-p effects vary depending on the type of cell and the state of
the cell, however, in general terms, it inhibits proliferation of a wide variety of cell
types, including the epithelial cells ofthe prostate. The ability of TGF-P to inhibit cell
growth enables it to act as a potent tumor suppressor. It inhibits cell proliferation by
causing cell cycle arrest at the Gl phase. There are certain prostate cancer epithelial
cells that develop resistance to the inhibiting effects of TGF-P. Both TGF-P responsive
and TGF-P resistant prostate cancer cells lines are available. These TGF-P resistant
cell lines include PC3M and LNCap cells. In the DU145 cell line, the TGF-P signaling
pathway is intact; therefore, inhibition of proliferation takes place in response to
exogenous TGF-p. It has been hypothesized that TGF-p inhibits epithelial cell growth
in DU145 acting through the Activating Protein-1 (AP-1) family ofproteins.
AP-1 proteins are a family oftranscription factors that are classified as basic
leucine zipper proteins (bZIP). They are called bZIP because the DNA binding
structure consists of a region enriched in basic amino acids that is adjacent to a leucine
zipper that is characterized by several leucine residues (12). The basic region binds
DNA, whereas the leucine zipper mediates dimer formation with other AP-1 family
members. There are seven members ofthe AP-1 family of transcription factors, JunD,
cJun, JunB, cFos, bFos, Fral and Fra2.
Previous research done in S. Khan's lab shows the significant role that cJun and
JunD play in TGF-P inhibitory effects on cell proliferation. DU145 cells respond to
TGF-p by decreasing the protein levels of JunD, but the levels of cJun remain
unchanged. Experiments have shown that when JunD levels decrease this allows cJun
dimerization on the AP-1 site in the promoter region of TGF-P responsive genes. It is
speculated that through this mechanism, TGF-P responsive genes are able to inhibit the
proliferation of prostate epithelial cells. This hypothesis is supported by our previous
findings. When cJun was over-expressed in DU145 cells, this caused a decrease in
proliferation and enhanced inhibitory effects of TGF-p. However, when JunD was
over-expressed in DU145 cells, an increased rate ofproliferation was observed in these
cells. This prior work suggests that TGF-p functions through c-Jun and JunD to inhibit
cell proliferation by causing changes in specific gene expression.
Our preliminary studies (unpublished) indicate that TGF-P inhibits the expression of
JunD in DU145 prostate cancer cells and this reduction is associated with inhibitory
effects of TGF-P on cell proliferation. Therefore, we hypothesize that TGF-P
responsive (DU145) and non-responsive (PC3M) cells have different levels ofAP-1
proteins and that several members ofthe AP-1 family ofproteins are involved in the
inhibitory effects of TGF-P. To test the above hypothesis the following specific aims
will be investigated:
1. To confirm the differences in the growth inhibitory response ofDU145 and
PC3M cells to TGF-p.
2. To determine which AP-1 family members are expressed in PC3M and DU145
cell lines.
3. To determine the expression pattern ofAP-1 family members in these
prostate cancer cell lines in response to TGF-f3.
By carrying out these aims, a better understanding ofthe mechanisms involved in the
activation of AP-1 proteins in prostate cancer cells in response to TGF-(3 will be
achieved.
CHAPTER II
REVIEW OF THE LITERATURE
TGF-(3 Expression in Prostate Cancer
In the case of cancer cells, a shared characteristic is the production of growth
promoters and the loss of function oftumor suppressors. In searching for specific
features ofprostate cancer, it was discovered that TGF-(3 levels are higher in advanced
prostate cancers than in earlier stages ofprostate cancer and in the normal prostate. It
seems contradictory that malignant epithelial cells make high levels of TGF-(3, seeing
that it is such a potent growth inhibitor of epithelial cells (21). In vivo studies have
shown that TGF-(3l actually enhances prostate tumor growth and metastasis (1). The
mechanism by which prostate cancer cells, like PC3M, protect themselves from being
growth-inhibited by TGF-(3l in vivo is not clear (11). Unlike PC3M, in the cell line
DU145, the TGF-|3 functions as expected, therefore inhibition of epithelial cell growth
takes place. It is apparent that the TGF-(3 receptors and signaling pathways for growth
inhibition are intact in the DU145 cell line.
TGF-(3 Signaling and Cellular Response
TGF-(3 signaling is initiated by the binding of TGF-3 to its receptor type II
(TGFp-RII) then the complex binds receptor type I (TGF|3-RI) serine/threonine kinase
on the surface of the cell. This in turn causes RII to phosphorylate RI kinase domain
which then propagates the signal through the phosphorylation ofthe Smad proteins
(19). Recently, there have been studies indicating that AP-1 proteins interact directly
with Smad proteins to induce expression of TGF-[3 responsive genes (12). This
signaling pathway is known as the Smad dependent pathway. When working through
the Smad dependent pathway, AP-1 proteins along with Smads are transported into the
nucleus where they bind to specific sites in the promoter region of specific TGF-0
responsive genes. AP-1 proteins can also be involved in the Smad independent
pathway. Jun terminal kinases (JNKs) cause AP-1 proteins to become phosphorylated
which in turn increases or decreases gene expression ofAP-1 target genes (6).
AP-1 Regulation of Gene Expression
The AP-1 proteins are a family oftranscription factors that are classified as basic
leucine zipper proteins (24). The DNA binding structure consists of a region enriched
in basic amino acids, and adjacent to this basic region is a leucine zipper that is
characterized by several leucine residues (3). Whereas the basic region directly binds
the DNA, the leucine zipper mediates dimer formation with other AP-1 family
members.
The AP-1 dimers formed are comprised of Jun-Jun and Jun-Fos proteins. The Jun
family is made up of cJun, JunD, and JunB, while the Fos family consists of FosB,
cFos, Fral, and Fra2 (20). The Fos family does not form homodimers (27), therefore
AP-1 proteins can form 18 different dimeric combinations (26), including the Jun
homodimers and Jun-Fos heterodimers. The Jun and Fos proteins can also dimerize
with other bZIP proteins including those from ATF, MAF, and CNC subfamilies which
increases their combinatorial potential even more (8). The different combinations
determine which genes are regulated (3). These dimers then bind to TPA-response
element (TRE; TGACTCA) in the promoters of target genes and regulate transcription
(2). AP-1 proteins convert extracellular signals into changes in the expression of
specific target genes that have AP-1 binding sites in their promoter regions (7).
These proteins have been implicated in a large variety of biological processes
including cell differentiation, proliferation, apoptosis and tumor suppression. AP-1
proteins control these various processes through their ability to regulate the expression
and function of certain cell cycle regulators such as Cyclin Dl and p53 (18). AP-1
activity is modulated by interactions with other transcriptional regulators and is further
controlled by upstream kinases that link AP-1 to various signal transduction pathways,
including that of TGF-f3 (25). TGF-0 effects, through AP-1 proteins, may involve both
the Smad dependent and Smad independent pathway. In the Smad independent
pathway, phosphorylation by JNK leads to changes in AP-1 dependent gene expression.
Whereas, in the Smad dependent pathway, many of TGF-(3 dependent genes contain
SBE sites as well as AP-1 sites, and both work in a cooperative fashion to control gene
expression.
Previous studies have shown that AP-1 family oftranscription factors are involved
in TGF-P effects on cell proliferation (3). It has been shown that cJun is required for
the inhibitory effects of TGF-f3 on target cells (5). Previous studies that have been
performed in our lab also confirm that AP-1 proteins are indeed involved in TGF-(3
effects on prostate cancer cells. Furthermore, research shows that this mechanism may
involve the interaction between AP-1 and Smad proteins, as mentioned above (14).
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After the media containing the various concentrations of TGF- (3 was removed, 1.0
uC/mL of 3H-thymidine was added and the incorporation of 3H-thymidine into DNA
was determined after incubating for 4 hours. After this, 3H-hymidine was removed and
lmL of distilled water was added to each well. The cells were then sonicated and
transferred to the MilliPore Vacuum System and filtered using DE-81, ion-exchange
filters. The macromolecules, (including DNA) bind to these filters while free thymidine
is removed. The filters were washed and collected in scintillation vials and counted
using a liquid scintillation counter (10).
Specific Aim Two: To Determine which AP-1 Family Members are Expressed in
PC3M and DU145 Cell Lines
Rationale: The purpose of this aim is to determine which ofthe seven members of the
AP-1 family are present or absent in both DU145 and PC3M cells. The goal is to
determine the mRNA expression levels of AP-1 family members and the effects of
TGF-ponAP-lmRNAs.
Experimental Design
RNA Isolation and RT-PCR
Total RNA was isolated from prostate cells using TRIzol (Life Technologies)
followed by chloroform extraction and isopropanol precipitation. Cells were lysed by
adding 1 mL of TRIzol to the sample and incubating at 15-30°C for 2-3 minutes.
Chloroform was added (0.2 per mL of TRIzol) to the sample, and then it was
centrifiiged at 12,000g for 10 minutes at 8°C. RNA was removed from the aqueous
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phase and transferred to a fresh tube. RNA was precipitated from the aqueous phase by
adding isopropyl alcohol (0.5mL per lmL of TRIzol). Samples were incubated at 30°C
for 10 minutes and centrifuged at 12,000g for 10 minutes at 8°C. The supernatant was
removed and the pellet, containing the RNA precipitate, was washed with 75% ethanol.
The samples were mixed by vortexing and centrifuged at 7,500g for 5 minutes at 8°C.
This step was repeated and all ethanol was removed. The RNA pellet sat for 10 minutes
to ensure it was dry. The RNA pellet was redissolved in deionized distilled water and
the concentration oftotal RNA was determined using a spectrophotometer.
Two micrograms of total RNA was reverse transcribed in a reaction mixture
containing 10 mM dNTP, 400 U ofM-MLV reverse transcriptase IX RT buffer,
0. lmM DTT and 0.5ng of oligo dT. The reaction mixtures were incubated for 1 hour at
37°C. After incubation, the samples were heated at 65°C for 5 min to inactivate the
enzyme. The cDNA samples were stored at -20°C. Samples of 1 ^l cDNA were added
to separate PCR reaction mixtures (total 10 ^.1) containing 0.1 mM dNTPs, 0.5 U Taq
DNA polymerase, PCR buffer with 3mM MgCl2 and specific primer pairs. GAPDH
and LI 9 primer pairs were used as internal controls. The samples went through PCR
reaction in the Rapid Cycler thermal cycler. The PCR products were visualized on 2%
agarose gels stained with ethidium bromide (28).
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Specific Aim Three: To Determine Quantitative Differences in the Expression
Pattern of AP-1 Family Members in Prostate Cancer Cells in
Response to TGF- (3
Rationale: The purpose ofthis aim is to determine how the expression levels of AP-1
family members from both cell lines change when treated with TGF-p. The goal is to
determine whether mRNA expression is upregulated/downregulated as a result of
TGF- P and to observe any differences in AP-1 mRNA expression between the cell
lines as a result of TGF- p treatment.
Experimental Design
Real-Time PCR
Reverse transcriptase PCR is a semi-quantitative procedure therefore real-time
PCR was employed because of the need to quantitate differences in mRNA expression .
Gene-specific primers have been designed using Beacon Designer software (tablel).
Primers were designed in the gene regions that were unique to the target genes, that is,
not homologous to any other gene in GeneBank, and to span long introns when
possible. Reverse transcription was performed for 1 h at 37°C in a reaction mixture
containing 10 mM dNTP, 400 U ofM-MLV reverse transcriptase IX RT buffer, 0.1mM
DTT and 0.5|ig of oligo dT and was stopped by incubation at 65°C for 5 minutes. Real
Time-PCR was performed using a master mix which consisted of RNAase free water
and SYBR Green Supermix (BioRad Laboratories). The reaction conditions for Real
time PCR were the following: 40 cycles consisting of 15 s incubation at 95°C and 1
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min incubation at 60°C on the I-Cycler IQ (BioRad, CA). Threshold cycle number (Ct)
for each reaction was obtained at the default baseline settings ofthe instrument
manufacturer. PCR reactions were run in duplicates to assess technical variability ofthe
assay. Experiments were repeated four times starting with independent cell cultures and
RNA isolation. Delta-delta Ct method was used for the calculation ofrelative gene
expression change caused by TGF-|3 treatment for each target gene. LI 9 gene was used
as internal standard gene to account for variability of input cell numbers, RNA
isolation, and reverse transcription procedures (27).
STATISTICAL ANALYSIS
Data were expressed as mean + SE. Statistical differences were analyzed using Student's t-
test. Differences were considered as statistically significant at the p< 0.05 level.
Table 1. Gene Primer Sequences for AP-1 Family Members
Accession AP-1 Product
(RefSeq §) members Length, hp








Note: These primer sequences were designed for the AP-1 family members using Beacon Designer 4.01 (Premier
Biosoft International) according to the manufactureer's preset defaults following GenBank cross-homology analysis.























TGF-p Inhibits DNA Synthesis in DU145 Cells
In normal epithelial cells, TGF-P inhibits growth and DNA synthesis. We examined
TGF-p effects in the DU145 cell line using 3H-Thymidine-incorporation procedure. Cells
were treated with 0 ng/mL (control), 0.1 ng/mL, 1.0 ng/mL and 10.0 ng/mL ofTGF-P for
18 hours (fig. 1). TGF-p in all tested concentrations inhibited DNA synthesis in DU145
cells, with a maximum effective concentration between 1 and 10 ng/mL of TGF-p. Data
presented here demonstrate that growth ofDU145 cells was inhibited by exogenous TGF-


























Fig. 1. Rate of DNA synthesis was determined using [3H]Thymidine-Incorporation.
DU145 cells were treated with 0.1 ng/mL, 1.0 ng/mL, and 10 ng/mL of TGF-B for 18
hours, (control, no TGF-B) . Cells were sonicated and filtered through the DE-81 filters
and [3H]Thymidine Incorporation into DNA was determined.
TGF-p Does Not Inhibit DNA Synthesis in PC3M cells
Under the aforementioned conditions, TGF(3 response was examined in PC3M
cells. We chose a concentration of 10.0 ng/mL of TGFP for treatment ofPC3M cells as it
was most effective in DU145 cells. PC3M cells treated with 10.0 ng/mL of TGF-|3

















Fig. 2. Rate ofDNA synthesis was determined using [3H]Thymidine-Incorporation.
PC3M cells were treated with 10 ng/ml ofTGF- P for 18 hours (control, no TGF- (3).
AP-1 Family Members Expressed in PC3M and in DU145 Cells
PC3M and DU145 cells were treated with TGF-|3 for 4 hours. Media were then
removed and total RNA was isolated. Total cellular RNA was used in semi-quantitative
RT-PCR to detect mRNA for JunD, cJun, JunB, FosB, cFos, Fral and Fra2 AP-1 family
members. In order to successfully isolate and purify this RNA, specific optimization
techniques were employed. Total RNA was isolated from 10 mm plates of DU145 and
PC3M cells using the appropriate amounts of TRIzol followed by chloroform extraction
and isopropanol precipitation. Appropriate controls were used to ensure that there was no
degradation or contamination of RNA. These included no template control, which
checked for cross contamination and no RT controls which checked for the presence of
genomic DNA (data not shown). In both DU145 and PC3M cell lines, all AP-1 family
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mRNAs were detected (fig. 3). RT-PCR results shown in figure 3 indicate significant
quantitative variation in the amounts of amplification products among different AP-1
genes and between cell lines in both control and TGF-fi treated cells. This suggested that
TGF-|3 has different effects on the expression levels ofthe AP-1 family members in
PC3M and in DU145. However, the more quantitative method to determine gene
expression, Real-Time PCR, was employed to measure differences in AP-1 gene
expression.
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Fig. 3. Detection ofmRNA expression for JunD, cJun, JunB, FosB, cFos, Fral and Fra2
AP-1 family members. RT-PCR was performed on total RNA isolated from TGF-I3-
treated (+) and non-treated (-) DU145 and PC3M cells. Samples were ran on 2% agarose
gels and visualized using ethidium bromide staining followed by imaging on BioRad
Imaging station.
20
TGF-P -Induced Changes in AP-1 Gene Expression in PC3M Cells
Expression levels of AP-1 family members in PC3M cells were determined using
real time RT-PCR method. Gene-specific primers were designed using Beacon Designer
software (table 1). Primers were designed in the gene regions that were unique to the
target genes (not homologous to any other gene in GeneBank) and to span long introns,
when possible. The conditions for RT-PCR were optimized as described in the Materials
and Methods section and reverse transcription was performed. Threshold cycle number
(Ct) for each reaction was obtained at the default baseline settings of the instrument
manufacturer. PCR reactions were run in duplicates to access technical variability ofthe
assay. Calculations of the fold changes caused by TGF-P treatments were done as
follows: Ct cycle numbers were first averaged between two technical duplicates and then
input into the following equation (27):
- [ACt treated - ACt control]
R =2
Where R is ratio of expression in treated over untreated samples
ACt treated = Ct target gene ~ Ct stnd.gene in treated Samples
ACt control = Ct target gene- Ct stnd.gene in untreated samples
The fold differences were averaged from three independent experiments and
plotted with standard errors of the mean (SEM) as shown in figure 4.
The results (fig. 4) indicate that TGF-P significantly upregulated Fra2 and FosB and
significantly downregulated JunD and Fral mRNAs (indicated by asterisks). Results
shown previously indicated that TGF-P had no inhibitory effects on PC3M cells at the
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level of DNA synthesis. However, data presented here indicates that TGF-(3 does















Fra1 cFos cJun Fra2 Fos B
*p=.05
Fig. 4. Real-time PCR analysis ofgene expression in TGF- (3 treated PC3M cells. Cells
were treated with lOng/ml ofTGF- (3 for 4 hours. Total RNA was isolated using Trizol
as described in Materials and Methods. Reverse transcription was performed with 20 ug
ofRNA using random primers. Samples containing lug ofcDNA were subjected to PCR
using gene-specific primer pairs and SYBR-Green containing master mix (BioRad).
Detection in real time was done on the IQ ICycler (BioRad, Inc). Level of gene
expression in untreated cells was assumed to be 1, fold differences in gene expression
due to TGF-|3 treatment are shown.
TGF-|3 -Induced Changes in AP-1 Gene Expression in DU145 Cells
This Real-time PCR procedure was performed under the same conditions as the
previous experiment to determine the specific mRNA expression pattern ofAP-1 family
members in DU145 cells. The results depicted in figure 5 show that TGF-(3 exerted some
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effect on AP-1 gene expression levels; however, due to high experiment-to-experiment















JunD Jun B Fra1 cFos cJun Fra2 Fos B
Fig. 5. Real-time PCR analysis of gene expression in TGF- (3 treated DU145 cells. Cells
were treated with lOng/ml of TGF- (3 for 4 hours.
Comparison of Expression Pattern ofAP-1 Genes in TGF- (3 -Treated DU145 and PC3M
Cells
The results depicted in figure 6 compare the effects ofTGF-P on mRNA
expression levels ofthe AP-1 family members in DU145 and PC3M cells. These results
indicate that exogenous TGF-P altered mRNA expression levels ofthe AP-1 family
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TGF-P has a myriad of functions, including cellular proliferation, differentiation,
and function in a wide variety oftarget cells. However, as it pertains to the prostate
gland, the well known effect of TGF-|3 is to inhibit growth of prostate epithelial cells
(26). In response to preliminary studies (unpublished) that investigated the role ofJunD
in TGF-P inhibitory effects, we decided to examine all seven members ofthe AP-1
family. The primary objective ofthis project was to investigate which ofthe AP-1
family members are expressed and how their expression changes in response to
treatment with TGF-p in the DU145 cell line and in the PC3M cell line. There is little
information in the current literature on AP-1 proteins as it pertains to the TGF-P
signaling pathway in prostate cancer cells. As a result, much ofthis research was
preliminary effort in order to achieve a better understanding ofthe manner in which
AP-1 proteins play a role in TGF-P signaling in prostate epithelial cells.
The parent line ofPC3M is PC3 and literature confirms that PC3 cells contain
TGF-P receptors (9). Therefore, the PC3M cells should have been responding to the
inhibitory effects ofTGF-P, as does the parent line. Conversely, under conditions used
in the laboratory, PC3M cells did not respond to this effect, so we initially hypothesized
that perhaps the TGF-p signaling was impaired in this cell line. However, this research
suggests that TGF-P signaling is active in PC3M cells, but the effect is not inhibitory.
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The present findings confirm that TGF-P inhibits DNA synthesis in DU145 cells.
As a result this line was considered to be TGF-p responsive (11). However, under the
conditions that we used in the laboratory, TGF-P had no inhibitory effects on DNA
synthesis in PC3M cells, so this line was classified as TGF-P unresponsive. The PC3M
cell line is a metastasized line derived from liver metastasis of PC3 transplanted
prostate tumor in nude mice. Unlike the parent line, PC3M is very aggressive and
highly invasive (1). There have been few studies on the PC3M line, but many studies
on the parent line PC3 showed opposite results than those reported in the present study.
That is, that PC3 cells are growth inhibited by TGF-P (11). We conclude that the
differences in TGF-P response are due to the metastatic nature ofthe PC3M line in
contrast to that ofthe parent PC3 line or due to the different experimental conditions
used in the different studies (17).
After confirming that there was a difference in the growth response after
treatment with TGF-P, the next step was to determine whether or not the AP-1
members had some effect on the TGF-P inhibitory response. To do this we first
performed Reverse Transcriptase-PCR to examine which ofthe AP-1 family members
were expressed in both cell lines. We confirmed that all the AP-1 family members were
expressed in both DU145 and PC3M cells. Moreover, there were differences in the
expression levels ofthe mRNAs in the individual lines in response to TGF-P.
In DU145 cells the RT-PCR results showed that there was an increase in JunD, JunB,
and cJun expression levels and a decrease in Fra2 expression levels after being treated
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with TGF-P for 4 hours. Under the same conditions, the levels of Fral, cFos and FosB
were similar in the control and TGF-P treated samples.
In the DU145 cell line, there were changes in the expression of specific AP-1
members after treatment with TGF-P . Therefore, further experimentation was needed
to distinguish which ofthe AP-1 proteins may be directly involved in TGF-P inhibitory
effect in this line.
In PC3M cell line, RT-PCR results indicated that when TGF-P was added there
was a slight increase in the expression levels of cJun and the other AP-1 family
members had similar expression levels in both the control sample and the TGF-P-
treated sample. These results indicate that even though TGF-p did not inhibit DNA
synthesis in the PC3M line, it is exerting some effects on expression ofAP-1 proteins.
Therefore, TGF-P signaling is intact in these cells and through AP-1 family members,
TGF-P may be exerting one of its other functions in PC3M cells. In order to confirm
and quantify these RT-PCR findings in both cell lines, the more precise method of gene
expression, Real-Time PCR, was employed to measure AP-1 family gene expression.
The Real-Time PCR results clearly indicate that TGF-P had an effect on both of
the cell lines. In PC3M cells, TGF-p significantly upregulated Fra2 and FosB and
significantly downregulated JunD and Fral. This result is evidence that not only is the
TGF-P signaling intact in PC3M cells, but that TGF-P has an alternative role, one that
is distinct from the inhibition of cell proliferation (26).
The data generated in this study indicated that TGF-P had an effect on the AP-1
expression levels in DU145 cells. There was an increasing trend of JunD, JunB, cJun
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and FosB expression levels and a decreasing trend in Fral and JunD in response to
TGF-p.
The results for this experiment alone were inconclusive because the Real-Time
PCR results for DU145 were variable. Even though both PC3M and DU145
experiments were done under the same conditions at the same time, the results for
DU145 were not consistent. This variability could have been due to a number of
factors, including the biological nature of DU145 cell line. However, we compiled data
from the most reproducible experiments and compared both ofthe cell lines,
When examining both lines simultaneously, we noticed several AP-1 family
members had opposing expression profiles after the addition of TGF-P, namely JunD,
cFos and Fra2. In DU145, expression levels of JunD were increased, while expression
levels of cFos and Fra2 were decreased as a result of TGF-P treatment. Whereas in
PC3M cells, expression levels of JunD were decreased and there was an increase in
levels of cFos and Fra2. The findings presented here strongly suggest that the TGF-p
signaling pathway is intact in both cells lines. The results are also indicative of AP-1
family members being involved in the TGF-P signaling pathway in DU145 as well as
PC3M. These results also suggest that TGF-p induces separate and opposing effects on
AP-1 which result in differential biological responses in PC3M and DU145 cells. We
know that TGF-P receptors are present in both lines, so this varying of function may be
due to some differences in the post-receptor pathways in PC3M cells. This difference
can perhaps be accredited to the fact that the PC3M cell line is metastasized and highly
aggressive whereas DU145 cell line is not.
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In summary, the goal ofthis work was to attain a better understanding ofthe role
of specific members ofthe AP-1 proteins that aid TGF-|3 in the inhibition of cellular
proliferation. In the case ofPC3M cells, we confirmed that TGF-P has a role other than
cell inhibition, which may be due to the fact that PC3M is a highly aggressive,
metastatic line. In the DU145 cells we simply confirmed what is already known, that
TGF-P inhibits cell proliferation. In both cells lines our data strongly suggests that AP-
1 family members are involved in both TGF-P inhibitory function in the DU145 and its
alternative function in PC3M cells. Further studies must be carried out in order to
confirm exactly the alternative function of TGF-(3 in PC3M cells. Further studies in
S.Khan's laboratory, along with the findings presented here, will be able to clarify the
exact mechanism by which AP-1 proteins interact with TGF-(3 in order to perform its
various functions. Once this can be elucidated, it will lead to therapeutically targeting




1. Chien, I, and Shaw, G. 2001. Role of stimulatory guanine nucleotide binding
protein in proliferation ofPC3M prostate cancer cells. International Journal of
Cancer. 91: 46-54.
2. Chineov, Y., and Kerppola, T. 2001. Close encounters ofmany kinds: Fos-Jun
interactions that mediate transcription regulatory specificity. Oncogene, 20: 2438-
2452.
3. Eferl, R., and Wagner, E. 2003. AP-1: A double-edged sword in tumorigenesis.
Cancer. 3: 859-868.
4. Heinrich, R., Livne, E., Ben-Izhak, O., and Aronheim, A. 2004. The cJun
dimerization protein 2 inhibits cell transformation and acts as a tumor suppressor
gene. The Journal ofBiological Chemistry. 279: 5708-5715.
5. Hocevar, B., Howe, PH. 2000. Regulation of AP-1 activity by TGF-beta. Methods of
Molecular Biology. 142: 97-108.
6. Hocevar, B., Brown, T, and Howe, P. 1999. TGF-P induces fibronectin synthesis
through a c-Jun N-terminal kinase-dependent, smad4-independent pathway. The
EMBOJournal. 18: 1345-1356.
7. Jochum, W., Passugue, E. and Wagner, E. 2001. AP-1 in mouse development and
tumorigenesis. Oncogene. 20: 2401-2412.
8. Kaminski, B., Pyrzynska, B., Ciechomska and Wisniewska, M. 2000. Modulationof
the composition ofAP-1 complex and its impact on transcriptional activity.
Neurobiology. 60: 395-402.
9. Kim, Y., Ahn, J., Zelner, D., Shaw, J, Sensibar, W., and Kim H, Lee, C. 1996.
Genetic change in transforming growth factor- beta receptor type I gene correlates
with insensitivity to TGF-P in human prostate cancer cells. Cancer Research. 56:
44-48.
10. Khan, S., Ndjountche, L., Pratchard, L., Spicer,L., and Davis, J. 2002. Follicle-
stimulating hormone amplifies insulin-like growth factor I-mediated activation
of AKT/Protein kinase B signaling in immature rat sertoli cells. Endocrinology.
143: 2259- 2267.
30
11. Lamm, M., Sintich, S., and Lee, C. 1998. A proliferative effect oftransforming
growth factor- beta 1 on a human prostate cancer cell line, TSU-PR1.
Endocrinology. 139: 787-790.
12. Liberati, N., Datto,M., Frederick,!, Shen, X., Wong, C, Rougier- Chapman, E.,
Wang, X. 1999. Smads bind directly to the Jun family ofAp-1 transcription
factors. Biochemistry, 96: 4844-4849.
13. Livak, K., and Schmittgen, T. 2001. Analysis ofrelative gene expression data using
real-time PCR and the 2 - [ACt treated - ACt control] Method. Methods. 25: 402-
408.
14. Massague, J., and Wotton, D. 2000. Transcriptional control by the TGF-beta/Smad
signaling system. The EMBOJournal. 19: 1746-1754.
15. Millena, AC, Reddy, SC, Bowling, GH., Khan, SA. 2004. Autocrine regulation of
steroidogenic function of leydig cells by transforming growth factor-Alpha.
Molecular and Cellular Endocrinology. 30: 29-39.
16. Park, JL, Lee,M.G., Cho,K., Park, BJ., Chae, KS., Byun, DS.,Ryu,BK., Park YK.,
Chi,SG. 2003. Transforming growth factor beta-1 activates interleukin-6
expression in prostate cancer cells through the synergistic collaboration ofthe
Smad2, p38-NF-kappa, JNK and Ras signaling pathways. Oncogene. 28: 4314-
4332.
17. Russell, P., Bennett, S., and Strieker, P. 1998. Growth factor involvement in
progression of prostate cancer. Clinical Chemistry. 44: 705-723.
18. Shaulian, E., Karin, M. 2001. AP-1 in cell proliferation and survival. Oncogene. 20,
2390-2400.
19. Shi, Y., and Massague, J. 2003. Mechanisms of TGF-beta signaling from cell
membrane to the nucleus. Cell. 113: 685-700.
20. Short, J., Pfarr, C. 2002. Translational regulation ofthe JunD messenger RNA.
Journal ofBiological Chemistry. 277: 32697-32705.
21. Steiner, M., Zhou, Z., Tonb, D., and. Barrack, E. 1994. Expression oftransforming
growth factor- Betal in prostate cancer. Endocrinology 135: 2240-2247.
22. Steiner, M., Barrack, E. 1992. Transforming growth factor-betal overproduction in
prostate cancer: Effects on growth in vivo and in vitro. Molecular
Endocrinology. 6: 15-25.
31
23. Tomlinson, D., Freestone, S., Grace, O, and Thomson, A. 2004. Differential effects
of transforming growth factor-betal on cellular proliferation in the developing
prostate. Endocrinology. 145: 4292-4300.
24. Ubeda, M, Vallejo, M, and Habener, J. 1999. CHOP Enhancement of gene
transcription by interactions with Jun/Fos AP-1 complex proteins. Molecular
and Cellular Biology. 19: 7589-7599.
25. Verrecchia, F., Vindevoghel, L., Lechleider, R., Uitto, J., Roberts, A., and Maviel,
A. 2001. Smad3/AP-l interactions control transcriptional responses to TGF-beta
in a promoter-specific manner. Oncogene. 20: 3332-3340.
26. Westermarck, J., Weiss, C, Saffrich, R., Kast, J., Musti, A-M., Wessely, M,
Ansorge, W., Seraphin, B., Wilm, M., Valdez, B., and Bohmann, D. 2002.
DexH/D RNA helicase RHII/Gu is a novel co-factor for transcription factor c-
Jun.EMBO 7.21:451-60.
27. Yazgan, O., and Pfarr, C. 2002. Regulation of two JunD isoforms by Jun N-
terminal kinases. Journal ofBiological Chemistry. 277, 29710-29718.
28. Yamamura,Y.,Hua, X., Bergelson, S., and Lodish, H. 2000. Critical role ofsmads
and AP-1 complex in transforming growth factor- beta- dependent apoptosis.
Journal ofBiological Chemistry. 275, 36295-36302.
